+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Compounding Pharmacy Market 2023-2027

  • PDF Icon

    Report

  • 163 Pages
  • June 2023
  • Region: Global
  • TechNavio
  • ID: 5681530
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The compounding pharmacy market is forecasted to grow by USD 1,682.04 million mn during 2022-2027, accelerating at a CAGR of 2.18% during the forecast period. The report on the compounding pharmacy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing popularity of HRT fueling demand for compounded medications, the increasing prevalence of hormonal imbalance problems, and government regulations and initiatives.

The compounding pharmacy market is segmented as below:

By Product

  • Topical medications
  • Oral medications
  • Parenteral medications
  • Other medications

By Therapeutic Area

  • Pain management
  • Hormone replacement
  • Dermal disorders
  • Other therapeutic areas

By Geographical Landscape

  • North America
  • The U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
  • Asia
  • China
  • India
  • ROW
  • Australia
  • Argentina
  • Rest of the world
This study identifies the rising popularity of personalized medicines as one of the prime reasons driving the compounding pharmacy market growth during the next few years. Also, untapped opportunities in emerging markets and a global shortage of essential drugs will lead to sizable demand in the market.

The report on the compounding pharmacy market covers the following areas:

  • Compounding pharmacy market sizing
  • Compounding pharmacy market forecast
  • Compounding pharmacy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading compounding pharmacy market vendors that include ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, Athenex Inc., B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius SE and Co. KGaA, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC. Also, the compounding pharmacy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global compounding pharmacy market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global compounding pharmacy market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Therapeutic Area Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Therapeutic Area Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Topical medications - Market size and forecast 2022-2027
Exhibit 34: Chart on Topical medications - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Topical medications - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Topical medications - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Topical medications - Year-over-year growth 2022-2027 (%)
6.4 Oral medications - Market size and forecast 2022-2027
Exhibit 38: Chart on Oral medications - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Oral medications - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Oral medications - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Oral medications - Year-over-year growth 2022-2027 (%)
6.5 Parenteral medications - Market size and forecast 2022-2027
Exhibit 42: Chart on Parenteral medications - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Parenteral medications - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Parenteral medications - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Parenteral medications - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Product
Exhibit 50: Market opportunity by Product ($ million)
Exhibit 51: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Therapeutic Area
7.1 Market segments
Exhibit 52: Chart on Therapeutic Area - Market share 2022-2027 (%)
Exhibit 53: Data Table on Therapeutic Area - Market share 2022-2027 (%)
7.2 Comparison by Therapeutic Area
Exhibit 54: Chart on Comparison by Therapeutic Area
Exhibit 55: Data Table on Comparison by Therapeutic Area
7.3 Pain management - Market size and forecast 2022-2027
Exhibit 56: Chart on Pain management - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Pain management - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Pain management - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Pain management - Year-over-year growth 2022-2027 (%)
7.4 Hormone replacement - Market size and forecast 2022-2027
Exhibit 60: Chart on Hormone replacement - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Hormone replacement - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Hormone replacement - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Hormone replacement - Year-over-year growth 2022-2027 (%)
7.5 Dermal disorders - Market size and forecast 2022-2027
Exhibit 64: Chart on Dermal disorders - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Dermal disorders - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Dermal disorders - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Dermal disorders - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Therapeutic Area
Exhibit 72: Market opportunity by Therapeutic Area ($ million)
Exhibit 73: Data Table on Market opportunity by Therapeutic Area ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 France - Market size and forecast 2022-2027
Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 111: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 112: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 113: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ million)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Advance Pharmacy
Exhibit 123: Advance Pharmacy - Overview
Exhibit 124: Advance Pharmacy - Product / Service
Exhibit 125: Advance Pharmacy - Key offerings
12.4 Athenex Inc.
Exhibit 126: Athenex Inc. - Overview
Exhibit 127: Athenex Inc. - Product / Service
Exhibit 128: Athenex Inc. - Key offerings
12.5 B.Braun SE
Exhibit 129: B.Braun SE - Overview
Exhibit 130: B.Braun SE - Business segments
Exhibit 131: B.Braun SE - Key news
Exhibit 132: B.Braun SE - Key offerings
Exhibit 133: B.Braun SE - Segment focus
12.6 Fagron NV
Exhibit 134: Fagron NV - Overview
Exhibit 135: Fagron NV - Business segments
Exhibit 136: Fagron NV - Key news
Exhibit 137: Fagron NV - Key offerings
Exhibit 138: Fagron NV - Segment focus
12.7 Fresenius SE and Co. KGaA
Exhibit 139: Fresenius SE and Co. KGaA - Overview
Exhibit 140: Fresenius SE and Co. KGaA - Business segments
Exhibit 141: Fresenius SE and Co. KGaA - Key news
Exhibit 142: Fresenius SE and Co. KGaA - Key offerings
Exhibit 143: Fresenius SE and Co. KGaA - Segment focus
12.8 Institutional Pharmacy Solutions
Exhibit 144: Institutional Pharmacy Solutions - Overview
Exhibit 145: Institutional Pharmacy Solutions - Product / Service
Exhibit 146: Institutional Pharmacy Solutions - Key offerings
12.9 ITC Compounding Pharmacy
Exhibit 147: ITC Compounding Pharmacy - Overview
Exhibit 148: ITC Compounding Pharmacy - Product / Service
Exhibit 149: ITC Compounding Pharmacy - Key offerings
12.10 McGuff Co. Inc.
Exhibit 150: McGuff Co. Inc. - Overview
Exhibit 151: McGuff Co. Inc. - Product / Service
Exhibit 152: McGuff Co. Inc. - Key offerings
12.11 Nephron Pharmaceuticals Corp.
Exhibit 153: Nephron Pharmaceuticals Corp. - Overview
Exhibit 154: Nephron Pharmaceuticals Corp. - Product / Service
Exhibit 155: Nephron Pharmaceuticals Corp. - Key offerings
12.12 Olympia Pharmacy
Exhibit 156: Olympia Pharmacy - Overview
Exhibit 157: Olympia Pharmacy - Product / Service
Exhibit 158: Olympia Pharmacy - Key offerings
12.13 PenCol Specialty Pharmacy
Exhibit 159: PenCol Specialty Pharmacy - Overview
Exhibit 160: PenCol Specialty Pharmacy - Product / Service
Exhibit 161: PenCol Specialty Pharmacy - Key offerings
12.14 Rx3 Compounding Pharmacy
Exhibit 162: Rx3 Compounding Pharmacy - Overview
Exhibit 163: Rx3 Compounding Pharmacy - Product / Service
Exhibit 164: Rx3 Compounding Pharmacy - Key offerings
12.15 Triangle Compounding Pharmacy
Exhibit 165: Triangle Compounding Pharmacy - Overview
Exhibit 166: Triangle Compounding Pharmacy - Product / Service
Exhibit 167: Triangle Compounding Pharmacy - Key offerings
12.16 Valor Compounding Pharmacy
Exhibit 168: Valor Compounding Pharmacy - Overview
Exhibit 169: Valor Compounding Pharmacy - Product / Service
Exhibit 170: Valor Compounding Pharmacy - Key offerings
12.17 Wedgewood Village Pharmacy LLC
Exhibit 171: Wedgewood Village Pharmacy LLC - Overview
Exhibit 172: Wedgewood Village Pharmacy LLC - Product / Service
Exhibit 173: Wedgewood Village Pharmacy LLC - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 174: Inclusions checklist
Exhibit 175: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 176: Currency conversion rates for US$
13.4 Research methodology
Exhibit 177: Research methodology
Exhibit 178: Validation techniques employed for market sizing
Exhibit 179: Information sources
13.5 List of abbreviations
Exhibit 180: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global compounding pharmacy market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Therapeutic Area Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Topical medications - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Topical medications - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Topical medications - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Topical medications - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Oral medications - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Oral medications - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Oral medications - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Oral medications - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Parenteral medications - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Parenteral medications - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Parenteral medications - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Parenteral medications - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 50: Market opportunity by Product ($ million)
Exhibits 51: Data Table on Market opportunity by Product ($ million)
Exhibits 52: Chart on Therapeutic Area - Market share 2022-2027 (%)
Exhibits 53: Data Table on Therapeutic Area - Market share 2022-2027 (%)
Exhibits 54: Chart on Comparison by Therapeutic Area
Exhibits 55: Data Table on Comparison by Therapeutic Area
Exhibits 56: Chart on Pain management - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Pain management - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Pain management - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Pain management - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Hormone replacement - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Hormone replacement - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Hormone replacement - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Hormone replacement - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Dermal disorders - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Data Table on Dermal disorders - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Chart on Dermal disorders - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Dermal disorders - Year-over-year growth 2022-2027 (%)
Exhibits 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 72: Market opportunity by Therapeutic Area ($ million)
Exhibits 73: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibits 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 77: Chart on Geographic comparison
Exhibits 78: Data Table on Geographic comparison
Exhibits 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 111: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 112: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 113: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 114: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 115: Market opportunity By Geographical Landscape ($ million)
Exhibits 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 117: Impact of drivers and challenges in 2022 and 2027
Exhibits 118: Overview on Criticality of inputs and Factors of differentiation
Exhibits 119: Overview on factors of disruption
Exhibits 120: Impact of key risks on business
Exhibits 121: Vendors covered
Exhibits 122: Matrix on vendor position and classification
Exhibits 123: Advance Pharmacy - Overview
Exhibits 124: Advance Pharmacy - Product / Service
Exhibits 125: Advance Pharmacy - Key offerings
Exhibits 126: Athenex Inc. - Overview
Exhibits 127: Athenex Inc. - Product / Service
Exhibits 128: Athenex Inc. - Key offerings
Exhibits 129: B.Braun SE - Overview
Exhibits 130: B.Braun SE - Business segments
Exhibits 131: B.Braun SE - Key news
Exhibits 132: B.Braun SE - Key offerings
Exhibits 133: B.Braun SE - Segment focus
Exhibits 134: Fagron NV - Overview
Exhibits 135: Fagron NV - Business segments
Exhibits 136: Fagron NV - Key news
Exhibits 137: Fagron NV - Key offerings
Exhibits 138: Fagron NV - Segment focus
Exhibits 139: Fresenius SE and Co. KGaA - Overview
Exhibits 140: Fresenius SE and Co. KGaA - Business segments
Exhibits 141: Fresenius SE and Co. KGaA - Key news
Exhibits 142: Fresenius SE and Co. KGaA - Key offerings
Exhibits 143: Fresenius SE and Co. KGaA - Segment focus
Exhibits 144: Institutional Pharmacy Solutions - Overview
Exhibits 145: Institutional Pharmacy Solutions - Product / Service
Exhibits 146: Institutional Pharmacy Solutions - Key offerings
Exhibits 147: ITC Compounding Pharmacy - Overview
Exhibits 148: ITC Compounding Pharmacy - Product / Service
Exhibits 149: ITC Compounding Pharmacy - Key offerings
Exhibits 150: McGuff Co. Inc. - Overview
Exhibits 151: McGuff Co. Inc. - Product / Service
Exhibits 152: McGuff Co. Inc. - Key offerings
Exhibits 153: Nephron Pharmaceuticals Corp. - Overview
Exhibits 154: Nephron Pharmaceuticals Corp. - Product / Service
Exhibits 155: Nephron Pharmaceuticals Corp. - Key offerings
Exhibits 156: Olympia Pharmacy - Overview
Exhibits 157: Olympia Pharmacy - Product / Service
Exhibits 158: Olympia Pharmacy - Key offerings
Exhibits 159: PenCol Specialty Pharmacy - Overview
Exhibits 160: PenCol Specialty Pharmacy - Product / Service
Exhibits 161: PenCol Specialty Pharmacy - Key offerings
Exhibits 162: Rx3 Compounding Pharmacy - Overview
Exhibits 163: Rx3 Compounding Pharmacy - Product / Service
Exhibits 164: Rx3 Compounding Pharmacy - Key offerings
Exhibits 165: Triangle Compounding Pharmacy - Overview
Exhibits 166: Triangle Compounding Pharmacy - Product / Service
Exhibits 167: Triangle Compounding Pharmacy - Key offerings
Exhibits 168: Valor Compounding Pharmacy - Overview
Exhibits 169: Valor Compounding Pharmacy - Product / Service
Exhibits 170: Valor Compounding Pharmacy - Key offerings
Exhibits 171: Wedgewood Village Pharmacy LLC - Overview
Exhibits 172: Wedgewood Village Pharmacy LLC - Product / Service
Exhibits 173: Wedgewood Village Pharmacy LLC - Key offerings
Exhibits 174: Inclusions checklist
Exhibits 175: Exclusions checklist
Exhibits 176: Currency conversion rates for US$
Exhibits 177: Research methodology
Exhibits 178: Validation techniques employed for market sizing
Exhibits 179: Information sources
Exhibits 180: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global compounding pharmacy market: ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, Athenex Inc., B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius SE and Co. KGaA, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the rising popularity of personalized medicines.'

According to the report, one of the major drivers for this market is the growing popularity of HRT fueling demand for compounded medications.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ACPHARM QUEENSLAND Pty Ltd.
  • Advance Pharmacy
  • Athenex Inc.
  • B.Braun SE
  • Doughertys Pharmacy
  • Fagron NV
  • Fresenius SE and Co. KGaA
  • Institutional Pharmacy Solutions
  • ITC Compounding Pharmacy
  • Lee Silsby Compounding Pharmacy
  • McGuff Co. Inc.
  • Nephron Pharmaceuticals Corp.
  • Olympia Pharmacy
  • PenCol Specialty Pharmacy
  • QuVa Pharma Inc.
  • Rx3 Compounding Pharmacy
  • Triangle Compounding Pharmacy
  • Valor Compounding Pharmacy
  • Village Compounding Pharmacy
  • Wedgewood Village Pharmacy LLC